What Is a GI Bleed? Symptoms, Causes, and Treatment

A gastrointestinal bleed, commonly called a GI bleed, is any bleeding that occurs anywhere along the digestive tract, from the esophagus down to the rectum. It can show up as vomiting blood, passing black tarry stools, or seeing bright red blood during a bowel movement. GI bleeding accounts for roughly 400,000 hospital admissions per year in the United States alone, and the range of severity is enormous: some bleeds are so slow they go unnoticed for months, while others cause life-threatening blood loss in hours. Understanding what to look for, what causes it, and how doctors treat it can make a real difference in outcomes.

How GI Bleeds Are Classified

Doctors split GI bleeding into two broad categories based on where the bleeding starts. Upper GI bleeds originate above the ligament of Treitz, a piece of connective tissue that marks the junction between the duodenum and the jejunum. In practical terms, that means the esophagus, stomach, or the first part of the small intestine. Lower GI bleeds start below that point, in the rest of the small intestine, colon, or rectum. The distinction matters because the causes, symptoms, and treatments differ substantially between the two.

There is also a third, less common category sometimes called “obscure” GI bleeding. This refers to bleeding whose source is not found by standard upper endoscopy or colonoscopy. An estimated five percent of acute GI bleeds fall into this category, and they often originate in the small bowel, a stretch of intestine that is harder to reach and inspect with conventional tools.

Recognizing the Symptoms

Acute GI bleeding typically announces itself in one of three visible forms: hematemesis (vomiting blood or material that looks like coffee grounds), melena (black, tarry, foul-smelling stool), or hematochezia (bright red or maroon blood passed rectally).¹ Generally, hematemesis and melena point toward an upper source, while hematochezia suggests a lower source, but there are important exceptions. A very brisk upper GI bleed can push blood through the digestive tract fast enough that it comes out bright red, mimicking a lower bleed.

Not all GI bleeding is visible. Occult bleeding is too slow or too small in volume to change the appearance of stool or vomit. Instead, it shows up only through lab tests: iron-deficiency anemia on a blood count, a positive fecal occult blood test, or unexplained fatigue and lightheadedness from chronic blood loss. Occult bleeding is easy to miss and can persist for weeks or months before anyone notices.

When blood loss is rapid or severe, the person may also develop signs of hemodynamic instability: a fast heart rate, low blood pressure, dizziness when standing, cold and clammy skin, or confusion. These signs signal that the body is struggling to compensate for the lost volume and that emergency medical care is needed immediately.

Common Causes of Upper GI Bleeding

Peptic ulcers are the most frequent cause of upper GI bleeding. These are open sores in the lining of the stomach or duodenum, typically driven by infection with Helicobacter pylori bacteria or regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin. Peptic ulcers remain the leading diagnosis across age groups and clinical settings.²

Esophageal varices represent a different and particularly dangerous scenario. These are swollen veins in the lower esophagus that develop because of portal hypertension, the elevated blood pressure in the liver’s circulation that accompanies cirrhosis. Varices are found in about half of people with cirrhosis, and each year an additional five to fifteen percent of cirrhosis patients develop new varices or see existing ones worsen.³ When varices rupture, the bleeding can be massive and carries a high mortality rate. Treatment of acute variceal bleeding relies on a combination of drugs that lower portal pressure (such as terlipressin), antibiotics, and endoscopic therapy like band ligation or injection of a tissue glue called cyanoacrylate.⁴

A Mallory-Weiss tear is a laceration at the junction of the esophagus and stomach, usually brought on by forceful retching or vomiting. People with advanced alcoholic liver disease tend to bleed more severely from these tears and are more likely to rebleed compared to those without liver disease.⁵

Less common but worth knowing about is the Dieulafoy’s lesion, an abnormally large artery sitting just beneath the lining of the stomach or intestine. Unlike normal blood vessels, which taper as they branch outward, a Dieulafoy’s artery stays wide. When it erodes through the overlying tissue, it can bleed heavily and without warning. These lesions are notoriously hard to find because the surrounding tissue often looks normal, yet they respond well to endoscopic treatment once located.⁶

Common Causes of Lower GI Bleeding

Diverticular bleeding is the leading cause of major lower GI bleeding. Diverticula are small pouches that form in the colon wall, especially in older adults. Fewer than five percent of people with diverticulosis ever bleed, but when they do, the episode is typically painless and involves a large volume of bright red blood.⁷ Several factors raise the odds of a diverticular bleed, including use of NSAIDs, blood thinners, and calcium channel blockers, as well as conditions like coronary artery disease and diabetes.⁸ Roughly a quarter of people who bleed once will bleed again within two years.

Angiodysplasia is another important source, particularly in older adults. These are clusters of fragile, dilated blood vessels in the colon or small bowel wall. They can cause both sudden visible bleeding and slow occult bleeding over time.⁹ In elderly patients, angiodysplasia is an almost exclusive diagnosis, meaning it rarely shows up in younger people.²

Hemorrhoids, anal fissures, colorectal polyps, inflammatory bowel disease, and colorectal cancer round out the list of common lower GI sources. Of these, colorectal cancer is the one clinicians are most vigilant about ruling out, especially when someone over fifty presents with new-onset bleeding. A population-based study found that people on oral anticoagulants who developed lower GI bleeding were more likely to have colorectal cancer or colonic polyps as the underlying cause compared to non-users.¹⁰

What Happens When You Arrive at the Emergency Room

The first priority is stabilization. Medical teams assess heart rate, blood pressure, and mental status to gauge how much blood has been lost and how well the body is compensating. Intravenous fluids are started, and blood samples are drawn for a complete blood count, coagulation studies, and a blood type and crossmatch in case transfusion is needed.

For blood transfusion, research has shown that less is often more. A landmark trial compared a restrictive transfusion strategy (transfusing only when hemoglobin dropped below 7 g/dL) against a liberal approach (transfusing at 9 g/dL). Survival at six weeks was higher in the restrictive group, and rebleeding rates were lower as well.¹¹ A later systematic review pooling multiple trials confirmed these findings: restrictive transfusion was associated with about a third lower risk of death and roughly forty percent lower risk of rebleeding.¹² This may seem counterintuitive, but overtransfusion can raise portal pressure and trigger more bleeding, particularly in people with varices or liver disease.

If the patient takes blood thinners, doctors have to make a fast judgment call. All anticoagulants and antiplatelet drugs are typically stopped. For life-threatening bleeds that do not respond to initial resuscitation, reversal agents may be given to counteract the anticoagulant’s effect.¹³ For patients on warfarin with a significantly elevated INR, guidelines recommend a concentrated clotting factor product rather than fresh frozen plasma, because it works faster and more reliably.¹⁴

Endoscopy and Other Diagnostic Procedures

Endoscopy is the cornerstone of GI bleed diagnosis and, in many cases, treatment. For upper bleeds, an upper endoscopy (a flexible camera passed through the mouth) lets doctors visualize the bleeding source and often stop it on the spot. Guidelines recommend performing endoscopy within 24 hours of presentation. A trial tested whether doing it even sooner, within six hours, would improve outcomes. It did not: early endoscopy within six hours showed no reduction in 30-day mortality compared to endoscopy done between six and 24 hours.¹⁵ The within-24-hours window remains the standard recommendation.

When a bleeding source is found during endoscopy, the doctor has several tools to stop it. Clips can be placed directly on a bleeding vessel to pinch it shut, thermal probes can cauterize the area, and injection of dilute epinephrine can temporarily slow bleeding while another method is applied. Endoscopic clipping is specifically indicated for actively bleeding ulcers and ulcers with a visible vessel, even if it is not actively spurting at the moment.¹⁶

For lower GI bleeds, colonoscopy serves a similar dual purpose of diagnosis and treatment. However, because the colon needs to be relatively clean for the camera to see well, there is often a delay while the patient takes a bowel preparation. When the bleeding is too brisk for colonoscopy or the source cannot be found, CT angiography has become an important alternative. It is fast, widely available, and can pinpoint active bleeding to guide the next step.¹⁷

When the Source Cannot Be Found

In about five percent of GI bleeding cases, standard upper endoscopy and colonoscopy both come back normal. The bleeding is real, but its source lies in the small bowel, a roughly twenty-foot stretch of intestine that these conventional instruments cannot easily reach. Capsule endoscopy has become the go-to tool for this scenario: the patient swallows a pill-sized camera that takes thousands of images as it travels through the small bowel, and it has a high sensitivity for detecting causes of bleeding in this region.

Other options include tagged red blood cell scans, which are the most sensitive technique for detecting active bleeding and are especially useful for intermittent bleeds because imaging can continue over many hours.¹⁸ CT enterography is another noninvasive option for evaluating small bowel disease. And if a source is found deep in the small bowel, double-balloon enteroscopy lets a gastroenterologist both reach the site and deliver treatment during the same procedure.

Medical Management Beyond Transfusion

Alongside stabilization and endoscopy, medications play a key supporting role. Proton pump inhibitors (PPIs) are the backbone of medical therapy for upper GI bleeds, particularly those caused by peptic ulcers. By suppressing acid production, PPIs help stabilize blood clots that form over the bleeding site and reduce the risk of rebleeding. High-dose intravenous PPI therapy is typically started as soon as a peptic ulcer bleed is suspected and continued after endoscopic treatment.¹⁹

Octreotide, a synthetic version of the hormone somatostatin, is sometimes used as an adjunct. It works by reducing blood flow to the gut and lowering portal pressure, making it particularly useful in variceal bleeding. Its role in non-variceal bleeding is less established, though it has been studied in combination with PPIs in that context as well.²⁰

Risk Scoring and Why It Matters

Emergency departments use scoring systems to sort patients into risk categories quickly. These scores help answer the practical question every clinician faces at the bedside: can this person safely go home, or do they need to be admitted, observed, or rushed to endoscopy? The Glasgow-Blatchford Score (GBS) is one of the most widely used. It incorporates lab values like hemoglobin and blood urea nitrogen along with clinical signs such as heart rate and blood pressure. Patients who score zero on the GBS have a very low probability of needing intervention and can sometimes be managed as outpatients.

For upper GI bleeds, the Rockall score, AIMS65 score, and several newer models have also been developed, though no single score perfectly predicts all outcomes.²¹ For lower GI bleeds, the Oakland score was designed specifically for that purpose, and a prospective study found that it performed comparably to the GBS in predicting who would need transfusion, develop severe bleeding, or die in hospital.²² None of these scores are great at predicting whether a patient will rebleed or need a procedure like embolization, which means clinical judgment still fills the gaps.

How Age Changes the Picture

GI bleeding in children has a different set of causes than in adults. The etiology shifts with age, from vitamin K deficiency and cow’s milk protein allergy in newborns and infants to erosive esophagitis and gastritis that can appear at any pediatric age.²³ Some causes are unique to children and would not appear on an adult differential diagnosis, so pediatric GI bleeds require a different diagnostic mindset.

At the other end of the age spectrum, adults over 65 make up the majority of people hospitalized for upper GI bleeds. A large cohort study found that nearly three-quarters of upper GI bleed patients were 65 or older.² Older adults carry more comorbidities and are far more likely to be on antiplatelet or anticoagulant medications that both raise the risk of bleeding and complicate treatment. They also score higher on clinical risk scales, reflecting their greater vulnerability. Angiodysplasia, as noted earlier, is almost exclusively an elderly diagnosis. Interestingly, variceal bleeding is more common in younger adults, while non-variceal causes dominate in the elderly.

Preventing Recurrence

Stopping a GI bleed is only half the battle. Preventing the next one often requires a long-term plan. For people on antiplatelet drugs like aspirin who have had an ulcer bleed, the combination of aspirin plus a daily PPI is recommended over switching to a different antiplatelet drug alone. A meta-analysis found that in patients with aspirin-induced ulcer bleeding, adding a PPI to aspirin reduced the risk of recurrent upper GI bleeding by roughly 94 percent compared to switching to clopidogrel without a PPI.²⁴

For patients on blood thinners, the question of when to restart the anticoagulant after a bleed is a genuine dilemma. Keeping the blood thinner stopped protects against rebleeding but raises the risk of a stroke or a blood clot. Guidelines generally recommend resuming anticoagulant therapy once the acute bleed is controlled, with the timing tailored to the individual’s clot risk and bleed severity.¹⁴ After successful endoscopic treatment, immediate resumption of antiplatelet therapy alongside a PPI is advised to keep ischemic events at bay.²⁵

Beyond medications, addressing root causes matters: eradicating H. pylori infection in anyone with a peptic ulcer, avoiding NSAIDs whenever possible (or co-prescribing a PPI when they cannot be avoided), and managing liver disease aggressively in people at risk for varices. For diverticular bleeding, there is no proven way to prevent the first episode, but controlling modifiable risk factors like NSAID use and working with a doctor on anticoagulation management may reduce the chance of recurrence.

The Role of Alcohol and Liver Disease

Alcohol deserves its own mention because it drives GI bleeding through multiple pathways. Chronic heavy drinking damages the liver, leading to cirrhosis and portal hypertension, which in turn produces varices. But even setting varices aside, about thirty to forty percent of acute GI bleeding in people with advanced alcoholic liver disease comes from non-portal-hypertension sources like peptic ulcers, Dieulafoy’s lesions, and Mallory-Weiss tears.⁵ Dieulafoy’s lesions appear to be more frequent in these patients, and when they bleed, the mortality is especially high. Mallory-Weiss tears, often triggered by binge-drinking-induced vomiting, are both more common and more severe in people with underlying liver disease. The coagulopathy that comes with a damaged liver, where the liver cannot produce enough clotting factors, compounds every bleed regardless of its source.

Interventional Radiology as a Backup

When endoscopy fails to stop the bleeding, or when the patient is too unstable for an endoscopic procedure, interventional radiology steps in. Angiographic embolization involves threading a catheter through the blood vessels to the site of the bleed and injecting material that blocks the feeding artery. This technique can be lifesaving for both upper and lower GI bleeds that resist other treatment. CT angiography is often used as the triage tool: if it shows active contrast extravasation (a sign of ongoing bleeding), the patient can go straight to the interventional radiology suite rather than back to the endoscopy unit.¹⁷ Surgery is reserved as the last resort, typically when both endoscopy and embolization have failed or when the bleeding is so massive that time does not allow for less invasive approaches.